Repositioning genes awakens fetal hemoglobin to treat disease. CRISPR editing may change future gene therapy. Researchers ...

Ocugen has a valuable IP portfolio, which should give it funding options. OCGN’s cash runway remains the main risk. Check out ...

Researchers have found a promising new method for gene therapy. They successfully restarted inactive genes by bringing them ...

At Miami-Dade’s public hospital system Jackson Health, new advancements in genetic research recently helped doctors modify a ...

Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...

When Americans imagine the future, it always has a lot to do with flying cars, robot housekeepers, and just about anything ...

"Comprehensive Review Highlights Market Growth, Innovation, and Investment Trends Driving the Future of Cell and Gene Therapy Tools, Biomanufacturing, and Gene Synthesis" BOSTON, June 20 ...

Massey Comprehensive Cancer Center have discovered a new genetic target that could possibly shape the future of treatment for liver ...

A new study highlights a historic step in personalized medicine, utilizing CRISPR gene-editing technology for a ...

For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than addressing the root cause of disease. However, cell and gene therapy (CGT) is ...

Crispr investors have had a year to put aside so far, with the stock down 25%. Read more on CRSP's execution risks, high ...